Advertisement
YOU ARE HERE: LAT HomeCollections

EARNINGS

January 22, 1988

Genentech reported income of $42.2 million for 1987, contrasted with a loss of $353 million in 1986. Operating revenue totaled $230.5 million, up 72% from 1986. The South San Francisco biotechnology firm attributed the results to the fourth-quarter launch of Activase, which is used to dissolve blood clots in coronary arteries that cause heart attacks, and increasing sales of Protropin human growth hormone.

Advertisement
Los Angeles Times Articles
|
|
|